about
Genomic cloning of methylthioadenosine phosphorylase: a purine metabolic enzyme deficient in multiple different cancersHijacking the Hexosamine Biosynthetic Pathway to Promote EMT-Mediated Neoplastic PhenotypesFunctional studies on the candidate ATPase domains of Saccharomyces cerevisiae MutLalpha.PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challengesSurvival and death signals can predict tumor response to therapy after oncogene inactivationDesigning a broad-spectrum integrative approach for cancer prevention and treatment.A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas.Unscreened older men diagnosed with prostate cancer are at increased risk of aggressive disease.End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancerFocal radiation therapy combined with 4-1BB activation and CTLA-4 blockade yields long-term survival and a protective antigen-specific memory response in a murine glioma model.Baseline hemoglobin-A1c impacts clinical outcomes in patients with pancreatic cancerOrthovoltage intraoperative radiation therapy for pancreatic adenocarcinoma.PET imaging of tumor neovascularization in a transgenic mouse model with a novel 64Cu-DOTA-knottin peptide.Acute toxicity of second generation HIV protease-inhibitors in combination with radiotherapy: a retrospective case series.Concurrent versus sequential sorafenib therapy in combination with radiation for hepatocellular carcinoma.Low interrater reliability in grading of rectal bleeding using National Cancer Institute Common Toxicity Criteria and Radiation Therapy Oncology Group Toxicity scales: a survey of radiation oncologists.Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cellsEfficacy of platinum chemotherapy agents in the adjuvant setting for adenosquamous carcinoma of the pancreas.Targeting DDX3 with a small molecule inhibitor for lung cancer therapy.EXO1-A multi-tasking eukaryotic nuclease.Interim-treatment quantitative PET parameters predict progression and death among patients with Hodgkin's disease.Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition.Favorable outcomes in locally advanced and node positive prostate cancer patients treated with combined pelvic IMRT and androgen deprivation therapyA mutation in EXO1 defines separable roles in DNA mismatch repair and post-replication repair.Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final resultsProstate cancer: Case volume and improved outcomes across cancer carePractice-based evidence to evidence-based practice: building the National Radiation Oncology Registry.Lymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients With Unresectable Pancreatic CancerLong-term survivors using intraoperative radiotherapy for recurrent gynecologic malignancies.Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma.Solitary plasmacytoma of the penile urethra treated with primary radiotherapy.Ganetespib radiosensitization for liver cancer therapyMolecularly targeted agents as radiosensitizers in cancer therapy--focus on prostate cancer.Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions.Very High-Risk Localized Prostate Cancer: Outcomes Following Definitive Radiation.Cyberknife for brain metastases of malignant melanoma and renal cell carcinoma.Radiosensitizers in pancreatic cancer--preclinical and clinical exploits with molecularly targeted agents.Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomasThe Association Between Chemoradiation-related Lymphopenia and Clinical Outcomes in Patients With Locally Advanced Pancreatic Adenocarcinoma.
P50
Q24606341-7D6A84CC-0F81-4704-AF44-ED189AF64080Q26752391-4F420F4D-F95A-46DF-94A8-119B331BBD65Q27929951-B4DAB62A-A4BF-44ED-B950-6756E0F9332BQ28067404-EB155D1F-DDA6-4B57-A743-084240C9F2C6Q30574736-6FC818F6-476A-4A38-8AB5-349C89850238Q30736359-6B1DE0B6-2FED-4032-B0C4-5061AF9A141DQ32173730-11FDEEBA-938D-4DD8-8A90-506FEB2BC28EQ33332189-20117C83-BF18-47C0-949B-66B86A6205D7Q33676037-7C1AAC8A-CE9B-4D50-90F2-B6C26EB9775BQ33676155-2958303E-C512-499D-8758-5425808543B2Q33889603-CC0F14B5-A412-4407-980F-55752D03A1E7Q33924966-3FE34B3C-53FD-4D84-8B68-8C7FFAEFD44DQ34331762-3642B511-3BE0-4528-93F5-801FEF101529Q34677001-B36588C0-7BDC-416E-A550-6A226DD9B7A5Q34722581-323FD251-A98F-4679-AEFA-7C7732B7EF9BQ34770140-32D1D904-DA32-4B19-9B68-00EF884F57B6Q34772278-19B37F7E-70A6-4FDF-BBE9-2C16253B8A43Q35024079-3BE5D550-D790-4618-B9C1-57A0245095F4Q35028999-3885EA3E-3CBB-4B8A-B92A-78E50351F68BQ35822589-44B98BB0-1AEF-46E5-9F0C-5136C185A4CAQ35913244-B5A42BC3-2967-484D-AD59-A30E56A5A561Q36099062-A572FE8F-6691-4A0A-8FD2-D60611039D86Q36144711-2FDB2E72-98C8-4B89-B01C-51AFB26DAC59Q36293177-38415472-C7CC-4171-87B1-57EE371C8CC3Q36749550-AC65F54D-8978-490B-B51E-C54C2FCFDF79Q36764997-D71769DE-84A1-4622-853D-66103F5DDDEAQ36767564-9498115B-1962-46DA-86C9-945982B605E1Q36835988-B8E634F2-BF4B-462E-845E-70A80D377216Q36842981-0901F164-0046-4440-B639-FADDD5F5844EQ36846111-559B892B-4EF0-4561-B86F-F3CD77538B04Q36907372-1A21432D-005E-4400-8F05-5CD0A1EF8BD4Q36925132-2D08A4BC-C9C5-444C-A0BF-B5D5CEFFC6BFQ37013260-550686C1-9258-4FE2-BE6B-9F27753DF982Q37092020-6BBF384D-0F7F-4D08-87BE-22DC565A8C00Q37285956-7F741F0D-61B2-4C18-8FE1-5A9E828CE4E8Q37342181-0BCB1F80-9C39-438B-B754-913EDA8B78C8Q37375909-CB0B8C3A-9672-41F5-85A4-5F86721507C2Q37403232-FD824759-2336-4B37-93D8-AA9E4840262FQ37658308-04E7855E-C922-462B-ACE2-17D3FEE01670Q37710295-9EC5BA8E-FB86-4BDF-9DFC-1E24D0DA95C6
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Phuoc T. Tran
@ast
Phuoc T. Tran
@en
Phuoc T. Tran
@es
Phuoc T. Tran
@nl
Phuoc T. Tran
@sl
type
label
Phuoc T. Tran
@ast
Phuoc T. Tran
@en
Phuoc T. Tran
@es
Phuoc T. Tran
@nl
Phuoc T. Tran
@sl
prefLabel
Phuoc T. Tran
@ast
Phuoc T. Tran
@en
Phuoc T. Tran
@es
Phuoc T. Tran
@nl
Phuoc T. Tran
@sl
P106
P1153
7102073122
P31
P496
0000-0002-0147-0376